-
Dabigatran Etexilate: Oral Direct Thrombin Inhibition
2026-09-25
Blommel and Blommel review dabigatran etexilate as an oral prodrug that produces rapid, predictable anticoagulation through direct thrombin inhibition, without relying on cytochrome P450 metabolism. The review explains its potential advantages over older anticoagulants while emphasizing renal-function-based dosing, bleeding risk, and the limits of the evidence available at publication.
-
Biotin Azide for Probing Lipid-Regulated Wnt Signaling
2026-09-25
Biotin Azide offers a click-chemistry route for capturing alkynylated biomolecules, but its value depends on matching the labeling strategy to the biological question. This article translates findings on cholesterol-regulated Frizzled5 signaling into a careful assay-design framework—and clarifies what biotin capture can and cannot establish.
-
N1-Methylpseudouridine in mRNA Workflows
2026-09-24
N1-Methylpseudouridine can be a useful variable when optimizing mRNA-driven gene activation, but assay success depends on distinguishing the free nucleoside from the triphosphate substrate required for in vitro transcription. This guide connects modified-mRNA design to CRISPRa splice assays, with practical controls for separating improved translation from changes in transcription or cell stress.
-
Ko 143 and BCRP: From Efflux to Exposure
2026-09-24
Ko 143 is a selective BCRP inhibitor for studying how ABCG2-mediated efflux shapes cellular drug response and systemic exposure. This article connects cancer-resistance experiments with quercetin pharmacokinetic findings to show how to distinguish transporter effects from metabolism and formulation effects.
-
Calpain Inhibitor I, ALLN: Practical Workflow
2026-09-23
Calpain Inhibitor I, ALLN (SKU A2602) provides a biochemical tool for studying calpain I/II and cathepsin B/L inhibition in apoptosis, inflammation, and ischemia-reperfusion workflows. It is intended for controlled scientific research only, not for diagnostic, therapeutic, or clinical use, and cellular or animal dosing must be optimized empirically.
-
Ko 143 for Reliable BCRP Assays
2026-09-23
This scenario-based guide explains how Ko 143 (SKU A3533) can separate BCRP-mediated drug efflux from nonspecific cytotoxicity, solvent effects, and broader multidrug resistance. It provides practical assay-design, optimization, interpretation, and product-selection guidance for reproducible cell and in vivo BCRP inhibition studies.
-
AG-221 Enasidenib Workflows for IDH2 AML
2026-09-22
AG-221 (Enasidenib) connects mutant IDH2 inhibition with measurable 2-hydroxyglutarate reduction, differentiation, and metabolic-resistance studies. This practical workflow shows how to pair metabolite, phenotype, and CD44-centered readouts for more informative acute myeloid leukemia research.
-
Norepinephrine Bitartrate: Assay Design Guide
2026-09-21
Norepinephrine bitartrate is more than a vasopressor reference compound: its salt identity, receptor profile, and handling requirements directly shape assay interpretation. This guide explains how to design reproducible adrenergic signaling and cardiomyopathy research workflows around formulation-aware reporting.
-
Uridine, Trisodium Salt in RNA Workflows
2026-09-21
Uridine, Trisodium Salt supports controlled studies of RNA metabolism, enzymatic RNA biosynthesis, and vascular responses while complementing RNA-only genome-engineering workflows. This guide translates the PRINT study into practical assay design, reagent handling, dose-screening, and troubleshooting decisions without treating uridine as a substitute for transcription-grade UTP.
-
Capsaicin: TRPV1 and KDM1A Research Guide
2026-09-20
Capsaicin, also called (E)-Capsaicin, activates TRPV1 and inhibits KDM1A/LSD1 in distinct experimental systems. The evidence supports applications in pain, inflammation, sensory-neuron, and gastric-cancer research, but assay potency and clinical effects should not be treated as interchangeable.
-
Bradykinin: Practical Assay Workflow
2026-09-19
Bradykinin (BA5201) provides a research stimulus for studying endothelium-dependent vasodilation, vascular permeability, smooth muscle responses, pain mechanisms, and inflammation-related signaling. It is intended for controlled scientific assays only, not for diagnostic, therapeutic, or medical use, and solutions should be prepared for prompt use rather than long-term storage.
-
Norepinephrine bitartrate: Applied Workflows
2026-09-19
Build more reproducible adrenergic signaling, cardiomyopathy research, and cardiovascular assays with a defined norepinephrine bitartrate workflow. This guide connects concentration control, salt-form-aware calculations, fresh-solution handling, and translational interpretation of vasopressor-equivalence data.
-
Aedes aegypti Xenobiotic Transport and Olsalazine
2026-09-18
Kennel and Rouhier paired xenobiotic clearance measurements with qPCR profiling of six putative organic cation transporters in female Aedes aegypti. The study found that molecular structure strongly influenced excreted-material volume, composition, and mortality, whereas short-term transporter-expression changes were limited.
-
Q-VD-OPh in Anastasis and Caspase-Controlled Assays
2026-09-18
Q-VD-OPh is a cell-permeable pan-caspase inhibitor that helps separate caspase activation from irreversible cell loss. This guide applies it to anastasis research, assay design, neurodegeneration models, and post-cryopreservation viability studies.
-
Atrial Natriuretic Peptide: Applied Workflows
2026-09-17
Build reproducible blood pressure, renal sodium-handling, and adipose-metabolism assays with a defined rat ANP peptide hormone input. This practical guide combines product-specific handling with a causal experimental framework adapted from a mechanistic animal study.